The present invention relates to the use of a TNF Receptor together with a steroid
hormone to produce a pharmaceutical composition for the treatment of lethal bacterial
and viral infections as well as autoimmune and inflammatory diseases. It also relates
to said pharmaceutical compositions for the simultaneous, separate or sequential
use of its active ingredients for the above specified treatment.
In particular, it relates to the use of TBP-1 together with dehydroepiandrosterone
(DHEA) or its metabolites to produce a pharmaceutical composition for the treatment
of septic shock.